ERRFI1 and neoplasm: Consequently, the paradoxical transition of ERRFI1 from a tumor suppressor that can mitigate the oncogenic effect of GC to a tumorigenic factor in advanced TNBC, in addition to the complex transcriptional network coordinated by GR, may partially explain the ineffective or adverse outcomes of GC therapy in TNBC.